Related Experiment Videos
Dr. Arvid Lindau and discovery of von Hippel-Lindau disease
Kristin Huntoon1,2, Edward H Oldfield1,3, Russell R Lonser1,2
1Department of Neurological Surgery, The Ohio State University Wexner Medical Center, Columbus, Ohio;
Abstract:
Arvid Lindau, MD, PhD, consolidated the disparate array of benign and malignant visceral and nervous system lesions into the neoplastic syndrome known as von Hippel-Lindau (VHL) disease. Based on this pioneering work, Dr. Lindau was awarded both a Rockefeller fellowship to work in Dr. Harvey Cushing's laboratory in Boston, Massachusetts, and the Lennmalm Prize. While working in Dr. Cushing's laboratory, Dr. Lindau continued his study of CNS hemangioblastomas. His work with Dr. Cushing led to their lifelong friendship and scientific collaboration. In this paper the authors describe Arvid Lindau's pioneering work in nervous system tumor pathology, his relationship to Dr. Cushing, and his role in advancing neurological surgery and research in Europe.